MedTabula: Never Get Stuck Without Epipen Again icône

2.1 by Android Course, Technion


Jan 23, 2020

À propos de MedTabula: Never Get Stuck Without Epipen Again

MedTabula est une application dont le but est d'aider à combler l'énorme pénurie d'Epipen

With MedTabula you never have to worry about forgetting your Epipen again. With just one click you can find places and people that are willing to share their Epipen in case you need one.

- Apart from giving you information where you can find Epipen around you, MedTabula also ensures that in case of a real emergency, it got your back - Speed dial to emergency services is available with a press of a button, as well as notifying your surroundings you are having an allergy attack and need someone to take care of you as soon as possible.

- Our goal is to help with the huge shortage in Epipen and we rely on the kindness of people willing to share their Epipen, however, we are aware that if you did decide to share your's you'd probably want it back - that's why we keep a list of all the people you shared your Epipen with/borrowed from.

Chargement de la traduction...

Informations Application supplémentaires

Dernière version

Demande MedTabula: Never Get Stuck Without Epipen Again mise à jour 2.1

Nécessite Android

4.1 and up

Voir plus

Quoi de neuf dans la dernière version 2.1

Last updated on Jan 23, 2020

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Voir plus

MedTabula: Never Get Stuck Without Epipen Again Captures d'écran

Articles populaires dans les dernières 24 heures

Charegement du commentaire...
Recherche en cours...
Abonnez-vous à APKPure
Soyez le premier à avoir accès à la sortie précoce, aux nouvelles et aux guides des meilleurs jeux et applications Android.
Non merci
S'inscrire
Abonné avec succès!
Vous êtes maintenant souscrit à APKPure.
Abonnez-vous à APKPure
Soyez le premier à avoir accès à la sortie précoce, aux nouvelles et aux guides des meilleurs jeux et applications Android.
Non merci
S'inscrire
Succès!
Vous êtes maintenant souscrit à notre newsletter.